| abstract |
The present invention provides a novel compound containing a basic group useful as a medicine and use thereof. The general formula (I) A compound represented by the formula: And other symbols as described in the specification) have CXCR4 antagonistic action, and therefore CXCR4 mediated diseases such as inflammatory / immune diseases (eg rheumatoid arthritis, arthritis, retinopathy, lung fibrosis) Disease, transplanted organ rejection, etc.), allergic diseases, infectious diseases (eg, human immunodeficiency virus infection, acquired immune deficiency syndrome, etc.), psychiatric / neurological diseases, brain diseases, cardiovascular diseases, metabolic diseases, It is useful as a preventive and / or therapeutic agent for cancer diseases (for example, cancer, cancer metastasis, etc.), or a regenerative medicine agent. [Selection figure] None |